PublizoomAward notice Supplies
Framework contract for the reservation and supply of Foclivia
- Public buyer
- European Commission, DG HERA - European Health Emergency Preparedness and Response Authority
Brussels - Place of performance
- 1049 Brussels
not published: buyer's address - Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part. - Publication
- 14 April 2025
- Notice language
- English
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Framework contract for the reservation and supply of 27,403,200 (twenty-seven million four hundred three thousand two hundred) doses of pandemic influenza vaccines. There are 34 contracting authorities: European Commission (HERA / DG HR), BE, CY, DK, 16 landers of DE, EE, ES, FR, IS, IE, LV, LT, LU, MT, NL, NO, SI, FI
Awarded to
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| framework contract for the supply of the latest approved protein based COVID-19 vaccines European Commission, DG HERA - European Health Emergency Preparedness and Response Authority · 18 November 2025 |
HIPRA HUMAN HEALTH SL HIPRA SCIENTIFIC SL LABORATORIOS HIPRA SA |
– |
| Framework contract for supply of Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN®), a third-generation, non-replicating smallpox vaccine European Commission, DG HERA - European Health Emergency Preparedness and Response Authority · 31 October 2025 |
BAVARIAN NORDIC AS | – |
| Raamovereenkomst: aankoop CPT intra-vitreale injectie vzw Jessa Ziekenhuis · 22 October 2026 |
DE CEUNYNCK MEDICAL | €604,000 |
| Raamovereenkomst voor het leveren van Tocilizumab IV AZ Oudenaarde · 16 October 2026 |
Fresenius Kabi | €1,200,000 |
| Leveren van orale antibiotica UZ Leuven · 16 October 2026 |
Pfizer Viatris Arega Pharma EUMEDICA |
€1,032,354 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 243029-2025.